BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 69 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,378,957 | +1.8% | 532,570 | 0.0% | 0.98% | +57.1% |
Q3 2022 | $5,286,000 | +0.3% | 532,570 | 0.0% | 0.62% | +15.3% |
Q2 2022 | $5,272,000 | +15.0% | 532,570 | +14.4% | 0.54% | +31.2% |
Q1 2022 | $4,584,000 | +0.1% | 465,420 | 0.0% | 0.41% | -18.9% |
Q4 2021 | $4,580,000 | – | 465,420 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverPark Advisors, LLC | 799,001 | $7,930,000 | 2.58% |
Corbin Capital Partners, L.P. | 928,124 | $9,207,000 | 2.29% |
Cohanzick Management, LLC | 799,001 | $7,926,000 | 1.92% |
RPO LLC | 379,021 | $3,762,000 | 0.91% |
Arena Capital Advisors, LLC- CA | 300,000 | $2,978,000 | 0.90% |
Alpha Wave Global, LP | 532,570 | $5,286,000 | 0.62% |
MIZUHO SECURITIES USA LLC | 444,957 | $4,383,000 | 0.60% |
MMCAP International Inc. SPC | 599,321 | $5,945,000 | 0.47% |
GLAZER CAPITAL, LLC | 2,285,000 | $22,667,000 | 0.42% |
CVI Holdings, LLC | 292,563 | $2,904,000 | 0.22% |